Tilray Brands Announces 1-for-10 Reverse Stock Split on December 2

Tilray Brands, Inc. (NASDAQ: TLRY) will implement a 1-for-10 reverse stock split on Tuesday, December 2, 2023. This move aims to consolidate shares, adjusting the number of shares owned by shareholders after the market closes on Monday, December 1. The action comes as the company seeks to enhance its stock price and improve its market performance.

As of Friday, Tilray’s stock opened at $1.03, reflecting a 4.8% increase. With a market capitalization of approximately $1.16 billion, the company has faced fluctuations over the past year, recording a low of $0.35 and a high of $2.32. The stock currently shows a price-to-earnings ratio of -0.45 and a beta of 2.04, indicating higher volatility compared to the market.

Analysts Update Ratings and Price Targets

Recent analyst reports have prompted a reevaluation of Tilray’s stock. Wall Street Zen upgraded the company from a “strong sell” to a “hold” rating on October 11, while Jefferies Financial Group raised its price target from $1.50 to $2.00 and assigned a “buy” rating. In contrast, Weiss Ratings maintained a “sell (d-)” rating, and ATB Capital Markets downgraded its recommendation from “hold” to “strong sell.”

Currently, two analysts have given Tilray a buy rating, three have assigned a hold rating, and two have rated it a sell. According to MarketBeat.com, the consensus rating remains a “hold” with an average price target of $2.00.

Institutional Investors Show Interest

Several institutional investors have recently engaged with Tilray’s stock, reflecting increased interest. Oppenheimer & Co. Inc. established a new position valued at approximately $25,000 in the third quarter. Similarly, Silverlake Wealth Management LLC and Unified Investment Management acquired new stakes, also valued around $25,000 and $26,000, respectively. Y Intercept Hong Kong Ltd and HighPoint Advisor Group LLC made investments of about $30,000 and $33,000 in the same period.

These institutional investors now control approximately 9.35% of Tilray’s shares, indicating growing confidence among larger financial players in the company’s future prospects.

Tilray Brands is a key player in the cannabis industry, focusing on the research, cultivation, processing, and distribution of medical cannabis. The company operates in various countries, including Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Based in Canada, Tilray continues to navigate a challenging market landscape while aiming for growth and stability.